1. Home
  2. CPRX vs DBRG Comparison

CPRX vs DBRG Comparison

Compare CPRX & DBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • DBRG
  • Stock Information
  • Founded
  • CPRX 2002
  • DBRG 1991
  • Country
  • CPRX United States
  • DBRG United States
  • Employees
  • CPRX N/A
  • DBRG N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • DBRG Real Estate Investment Trusts
  • Sector
  • CPRX Health Care
  • DBRG Real Estate
  • Exchange
  • CPRX Nasdaq
  • DBRG Nasdaq
  • Market Cap
  • CPRX 2.8B
  • DBRG 2.7B
  • IPO Year
  • CPRX 2006
  • DBRG 2009
  • Fundamental
  • Price
  • CPRX $20.60
  • DBRG $12.70
  • Analyst Decision
  • CPRX Strong Buy
  • DBRG Strong Buy
  • Analyst Count
  • CPRX 6
  • DBRG 8
  • Target Price
  • CPRX $30.50
  • DBRG $18.13
  • AVG Volume (30 Days)
  • CPRX 984.3K
  • DBRG 2.8M
  • Earning Date
  • CPRX 11-06-2024
  • DBRG 11-01-2024
  • Dividend Yield
  • CPRX N/A
  • DBRG 0.32%
  • EPS Growth
  • CPRX 114.68
  • DBRG 1689.35
  • EPS
  • CPRX 1.18
  • DBRG 0.76
  • Revenue
  • CPRX $460,482,000.00
  • DBRG $876,649,000.00
  • Revenue This Year
  • CPRX $21.99
  • DBRG N/A
  • Revenue Next Year
  • CPRX $17.95
  • DBRG N/A
  • P/E Ratio
  • CPRX $17.48
  • DBRG $16.43
  • Revenue Growth
  • CPRX 32.17
  • DBRG 680.46
  • 52 Week Low
  • CPRX $13.00
  • DBRG $11.07
  • 52 Week High
  • CPRX $24.27
  • DBRG $20.99
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 39.71
  • DBRG 34.34
  • Support Level
  • CPRX $21.30
  • DBRG $12.15
  • Resistance Level
  • CPRX $24.27
  • DBRG $12.80
  • Average True Range (ATR)
  • CPRX 0.79
  • DBRG 0.56
  • MACD
  • CPRX -0.18
  • DBRG -0.22
  • Stochastic Oscillator
  • CPRX 4.18
  • DBRG 11.95

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

About DBRG DigitalBridge Group Inc.

DigitalBridge Group Inc is a developer of alternative asset manager dedicated to investing in digital infrastructure. The company's platform invests in and operates businesses across the digital ecosystem, including cell towers, data centers, fiber, small cells, and edge infrastructure, to provide clients with funds for digital infrastructure real estate infrastructure.

Share on Social Networks: